Ardelyx | ARDX - Net Income

Stock Price
5.87
Daily Change
-0.10 -1.68%
Monthly
-4.86%
Yearly
31.91%
Q2 Forecast
5.76

Ardelyx reported $-407K in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
Ardelyx USD -407K 562K Dec/2025
aTyr Pharma USD 24.56M 50.3M Dec/2025
Corcept Therapeutics USD 24.29M 4.62M Dec/2025
Curis USD 19.36M 31.16M Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
TG Therapeutics USD 23.04M 367.86M Dec/2025
United Therapeutics USD 364.3M 25.6M Dec/2025
Xoma USD -17.24M 33.23M Sep/2024